Sunday 18 October 2026
Export NUVOQ’s income statement to Excel — free account
Holdco Nuvo Group D.G Ltd.
NUVOQ Healthcare Medical Devices
Holdco Nuvo Group D.G Ltd.’s revenue for fiscal 2023 (year ended December 2023) was $176,000.00.
0.00
0.00
NaN
Follow NUVOQ
| Dec '23 | Sep '23 | Jun '23 | Mar '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+6 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.02 | 0.02 | 0.01 | 0.09 | |
Current Ratio |
0.05 | 0.04 | 0.09 | 0.18 | |
Net Debt/EBITDA |
(1.23) | 0.02 | 0.02 | 0.19 | |
Debt/Assets |
332.07% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
(0.17) | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.46 | 0.07 | 0.51 | (0.07) | |
Capex/Depreciation |
(0.17) | — | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | — | — | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.78) | 0.00 | (0.12) | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.78) | 0.00 | (0.12) | (0.02) | |
Cash per Share |
0.03 | 0.00 | 0.01 | 0.01 | |
Shareholders Equity per Share |
(3.74) | 0.00 | (3.32) | (1.29) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(3.74) | 0.00 | (3.32) | (1.29) | |
Free Cash Flow |
(13.99) | (0.34) | (0.48) | (0.15) | |
Working Capital |
(29.37) | (5.18) | (3.11) | (1.05) | |
Capital Expenditures |
(0.04) | — | — | — | |
Net Current Asset Value |
(69.40) | (49.61) | (47.13) | (278.66) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | — | — | — | |
| Other line items | |||||
Average Assets |
3.62 | 147.64 | 148.37 | 265.20 | |
Average Common Equity |
(53.10) | (13.82) | (11.10) | (9.96) |
Columns are period end dates